fda compounding glp-1 enforcement news today 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our Non-Traditional Channels: The Compounded GLP-1

Irisin, a myokine released during physical exercise, has emerged as a key mediator of muscle health and metabolic regulation

Objective Rheumatoid arthritis (RA) is an inflammatory disease associated with thromboembolic events

The change, advocates argue, would curb rising obesity rates, reduce health care disparities and save on health care costs.

Learn the science behind why progress slows and explore personalized treatment options that may help you break through and continue your weight management journey

However, growing research suggests these medications may also support individuals with Attention-Deficit/Hyperactivity Disorder (ADHD) by positively influencing mental function

If you're considering tirzepatide for weight management, Zepbound is the FDA-approved injectable option available today.